RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE

Suda Pharmaceuticals Equity 2024

Suda Pharmaceuticals Equity

8.98 M AUD

Suda Pharmaceuticals Dividend yield

Ticker

SUD.AX

ISIN

AU000000SUD7

WKN

A1J9SF

In 2024, Suda Pharmaceuticals's equity was 8.98 M AUD, a 0% increase from the 0 AUD equity in the previous year.

Suda Pharmaceuticals Aktienanalyse

What does Suda Pharmaceuticals do?

Suda Pharmaceuticals Ltd is an Australian pharmaceutical company specializing in the development and marketing of drugs. The company was founded in 2000 and is headquartered in Perth, Western Australia. It is listed on the Australian Stock Exchange and has offices in the UK and the USA. Suda Pharmaceuticals ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Equity Details

Analyzing Suda Pharmaceuticals's Equity

Suda Pharmaceuticals's equity represents the ownership interest in the company, calculated as the difference between total assets and total liabilities. It reflects the residual claim by shareholders on the company’s assets after all debts have been paid. Understanding Suda Pharmaceuticals's equity is essential for assessing its financial health, stability, and value to shareholders.

Year-to-Year Comparison

Evaluating Suda Pharmaceuticals's equity over successive years offers insights into the company's growth, profitability, and capital structure. Increasing equity indicates an enhancement in net assets and financial health, while decreasing equity could point to rising debts or operational challenges.

Impact on Investments

Suda Pharmaceuticals's equity is a crucial element for investors, influencing the company's leverage, risk profile, and return on equity (ROE). Higher equity levels generally suggest lower risk and enhanced financial stability, making the company a potentially attractive investment opportunity.

Interpreting Equity Fluctuations

Fluctuations in Suda Pharmaceuticals’s equity can arise from various factors, including changes in net income, dividend payments, and issuance or buyback of shares. Investors analyze these shifts to gauge the company's financial performance, operational efficiency, and strategic financial management.

Frequently Asked Questions about Suda Pharmaceuticals Stock

What is the equity of Suda Pharmaceuticals this year?

Suda Pharmaceuticals has equity of 8.98 M AUD this year.

What was the equity of Suda Pharmaceuticals compared to the previous year?

The equity of Suda Pharmaceuticals has increased/decreased by 0% decreased compared to the previous year.

What impact does a high equity have on investors of Suda Pharmaceuticals?

A high equity is advantageous for investors of Suda Pharmaceuticals as it is an indicator of the company's financial stability and its ability to manage risks and challenges.

What impact does low equity have on investors of Suda Pharmaceuticals?

A low equity can be a risk for investors of Suda Pharmaceuticals, as it can put the company in a weaker financial position and impair its ability to manage risks and challenges.

How does an increase in equity of Suda Pharmaceuticals affect the company?

An increase in equity of Suda Pharmaceuticals can strengthen the company's financial position and improve its ability to make investments in the future.

How does a reduction in the equity of Suda Pharmaceuticals affect the company?

A reduction in equity of Suda Pharmaceuticals can affect the financial situation of the company and lead to a higher dependence on debt capital.

What are some factors that influence the equity of Suda Pharmaceuticals?

Some factors that can affect the equity of Suda Pharmaceuticals include profits, dividend payments, capital increases, and acquisitions.

Why is the equity of Suda Pharmaceuticals so important for investors?

The equity of Suda Pharmaceuticals is important for investors as it is an indicator of the financial strength of the company and can be an indication of how well the company is able to fulfill its financial obligations.

What strategic measures can Suda Pharmaceuticals take to change the equity?

To change equity, Suda Pharmaceuticals can take various measures such as increasing profits, conducting capital increases, reducing expenses, and acquiring companies. It is important for the company to perform a thorough review of its financial situation to determine the best strategic actions to modify its equity.

How much dividend does Suda Pharmaceuticals pay?

Over the past 12 months, Suda Pharmaceuticals paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Suda Pharmaceuticals is expected to pay a dividend of 0 AUD.

What is the dividend yield of Suda Pharmaceuticals?

The current dividend yield of Suda Pharmaceuticals is .

When does Suda Pharmaceuticals pay dividends?

Suda Pharmaceuticals pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Suda Pharmaceuticals?

Suda Pharmaceuticals paid dividends every year for the past 0 years.

What is the dividend of Suda Pharmaceuticals?

For the upcoming 12 months, dividends amounting to 0 AUD are expected. This corresponds to a dividend yield of 0 %.

In which sector is Suda Pharmaceuticals located?

Suda Pharmaceuticals is assigned to the 'Health' sector.

Wann musste ich die Aktien von Suda Pharmaceuticals kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Suda Pharmaceuticals from 5/31/2024 amounting to 0 AUD, you needed to have the stock in your portfolio before the ex-date on 5/31/2024.

When did Suda Pharmaceuticals pay the last dividend?

The last dividend was paid out on 5/31/2024.

What was the dividend of Suda Pharmaceuticals in the year 2023?

In the year 2023, Suda Pharmaceuticals distributed 0 AUD as dividends.

In which currency does Suda Pharmaceuticals pay out the dividend?

The dividends of Suda Pharmaceuticals are distributed in AUD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Suda Pharmaceuticals

Our stock analysis for Suda Pharmaceuticals Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Suda Pharmaceuticals Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.